Test for Mycobacterium tuberculosis (TB) Expected to Highlight Broad On-Demand CE IVD Test Menu at Booth #611
SUNNYVALE, Calif., April 28 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today announced speaker and program highlights for its symposium, "Patient Management in the Era of Rapid Diagnostics," which the company will host at the 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), taking place in Finland next month. The company also announced the menu of CE IVD molecular diagnostic tests to be featured in booth #611 on the exhibition floor.
Dr. Fred Tenover, Ph.D., Cepheid's Senior Director of Scientific Affairs, will chair the symposium where leading microbiology and infection control specialists will present data on the clinical impact of rapid, on-demand molecular diagnostic testing.
The Cepheid Symposium, "Patient Management in the Era of Rapid Diagnostics," will take place at 9:00 a.m. on Sunday, 17 May in Hall 3F. The agenda is as follows:
9:00 MRSA in Paediatric Patients: What Rapid Testing Reveals Presented by Dr. Jim Gray, Senior Microbiologist, Birmingham Children's Hospital 9:30 Detecting C. difficile: Slowly or Quickly? Presented by Professor Mark Wilcox, Professor in Medical Microbiology, Institute of Molecular and Cellular Biology, Leeds 10:00 Do We Need Rapid Tests to Detect Tuberculosis and Rifampicin Resistance? Presented by Dr. Sabine Ruesch-Gerdes, National Reference Centre for Mycobacteria, Borstel, Germany 10:30 Will Community MRSA and C. difficile Change Infection Control in Hospitals? Presented by Dr. Fred Tenover, Cepheid, Sunnyvale, CA
"The 19th ECCMID Congress is shaping
Copyright©2009 PR Newswire.
All rights reserved